U.S. spot ETFs tracking Hyperliquid (HYPE) experienced $2.3787 million in net outflows on November 4, reversing the previous day's $605,100 inflow. Bitwise Hyperliquid ETF led the outflows with $1.411 million withdrawn, while 21Shares Hyperliquid ETF saw $967,700 outflows. Despite this, cumulative net inflows for the group remain strong at $298 million, with total assets under management at $411 million as of November 5. This fluctuation highlights short-term investor shifts but overall continued interest in Hyperliquid ETFs.
U.S. Hyperliquid (HYPE) Spot ETFs saw a net outflow of $2.38 million on November 4, reversing the previous day's inflow. For readers following the broader cryptocurrency market, here is Pluang's market snapshot as of Nov 06, 2026 11:51 WIB: out of 50 major cryptocurrencies priced on Pluang, only 3 rose while 46 fell. Notable movers include BAL (Balancer) up 11.14% at Rp16.297, UNI (Uniswap) down 10.57% at Rp125.324 with 83% sell order activity, and THETA (Theta Network) down 9.26% at Rp2.615.
The 2026 Global Health Congress in New York gathered over 625 healthcare leaders from 25 countries to discuss innovation, equity, and investment in healthcare. The event featured 350+ startup applications in its Healthcare Shark Tank competition, cro...
Ambarella, an edge AI semiconductor company, announced its third quarter fiscal year 2027 earnings conference call will be held on November 24, 2026, at 1:30 p.m. Pacific Time. The company will release its earnings report after the market closes that...
Kirby is rated HOLD at $140.82 with a base target of $155.23, reflecting moderate near-term upside. The company's marine segment is the main profit driver, showing a 17% revenue increase and 26% operating profit growth in Q3. Distribution & Services ...
A trader's Bitcoin position worth $15.6 million was liquidated during recent market declines, forcing the closure of the position due to insufficient collateral. Following this, the trader opened a new short position valued at $2.68 million on TRUMP ...
INOVIO Pharmaceuticals announced a public offering of approximately 58.7 million shares and pre-funded warrants to raise about $75 million before expenses. The offering price is set at $1.05 per share, with an option for underwriters to buy additiona...
